News

Scientists at Johns Hopkins and the University of Washington have figured out a new way to use living cells as tiny factories for building a specific protein. Working with cells derived from…

It wasn’t the most direct path to becoming a materials scientist, but Younan Xia ended up in his “dream job” with a bit of persistence, flexibility and appreciation for foundational…

To the naked eye, a piece of metal is just a piece of metal. But researchers like Tim Rupert, a professor of materials science and engineering and the Director of…

Cancer has a sweet tooth—and that craving might be more revealing than scientists once thought.

A team led by MatSci Department Head Michael Kessler is planning to convene the University Materials Council to discuss the future of materials science research and education.   The University Materials Council is made up of roughly 150 department…

A group of undergraduates set out to develop a biodegradable pancreatic and bile duct stent for patients healing from one of the most complex types of surgery for cancer.

Doctors insert more than 2 million tiny wire mesh tubes, or heart stents, into Americans’ blood vessels a year to treat heart disease, according to health care market research firm iData Research.  Stents are one of many implants…

Seemingly unrelated diseases and conditions like Alzheimer's disease, obesity, chronic pain, traumatic brain injury, and multiple sclerosis disrupt the blood-brain barrier. Peter Searson's lab is developing tissue-engineered models to figure out why—and fix it.

Materials science and engineering researchers have announced a new approach that makes the tiny fat‑based particles used to deliver RNA medicines — called lipid nanoparticles — far more consistent in…

GEMINI can “write” a lasting record of what cells experience over time, without getting in the way of their normal functions.

Johns Hopkins University researchers have developed a simple post-assembly crosslinking strategy that stabilizes mRNA lipid nanoparticles (LNPs), enhancing both their delivery efficiency and stability during storage.

Peter Searson is unravelling the complex mechanisms by which diseases of the brain disrupt the blood-brain barrier.